SureTrader
Home > Boards > Free Zone > Penny Trading - Technical > Sizzling Stock Picks

TR GM .0248 Coming back

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
$hellKing Member Profile
Member Level 
Followed By 519
Posts 34,144
Boards Moderated 3
Alias Born 06/14/04
160x600 placeholder
$hellKing Member Level  Friday, 01/12/18 11:14:07 AM
Re: None
Post # of 794929 
TR GM .0248 Coming back to life according to CEO. They will start filing again and have some restructuring. Could be a goodie. Seem pretty thin and only ARCA in the way with a few k til .05s. imo They have some major pipelines from website. So if they got anything new could send it up north

had recent 8k

https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12426636


OS updated pretty low for .02 stock Outstanding Shares 27,730,227 a/o Nov 03, 2017


Contact Info
2980 Beverly Glen Circle
Los Angeles, CA 90077

Website: http://www.tmedpharma.com/
Phone: (310) 474-9809
Email: investors@tmedpharma.com
Find us on: Twitter Facebook LinkedIn
Business Description
Targeted Medical Pharma, Inc. (OTCQB:TRGM) is a publicly traded, Los Angeles-based biotechnology company that develops amino acid based medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The company also develops a line of dietary supplements designed to support health and wellness. The company manufactures 10 proprietary amino acid based medical foods, and recently launched its first dietary supplement, Clearwayz. The products are sold directly to physicians, pharmacies and patients in the United States.

The company is currently developing amino acid based therapies designed for the oral stimulation of progenitor stem cells that differentiate into neurons, red blood cells, pituitary hormones including IGF-I.

Targeted Medical Pharma and its' subsidiary companies, Complete Claims Processing and Physician Therapeutics, provide healthcare practitioners and patients with clinically proven therapies required to safely and effectively manage disease without harmful side effects.

We are committed to delivering long-term value to investors by maintaining disciplined cost controls, optimizing capital investment and adhering to the highest standards of corporate governance.


Your stock trades are your own responsibility. No one forces you to make the trade. Always take responsibility for your own decisions and you will never have anyone else to blame
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist